Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Johannes Blatter"'
Autor:
Lonny Yarmus, Maurice Ndukwu, Daniel G. Lorch, Nicholas J. Pastis, Samira Shojaee, Jason Akulian, Alexander Chen, Johannes Blatter, Gerard A. Silvestri, Joseph Boscia, Frank Schippers, Momen M. Wahidi, Gregory Feldman
Publikováno v:
Chest. 152:A739
Publikováno v:
Anticancer research. 27(2)
Batch variability of sera used for cell culture is of considerable experimental concern. A novel fetal calf serum product, FCS Gold, was claimed to be the first defined fetal calf serum free of batch variation.The efficacy of methotrexate (MTX) and L
Autor:
Frank G, Perabo, Heike, Lindner, Doris, Schmidt, Dirk, Huebner, Johannes, Blatter, Rolf, Fimmers, Stefan C, Müller, Peter, Albers
Publikováno v:
Anticancer research. 23(6C)
Gemcitabine and paclitaxel are currently co-administered in clinical studies for bladder cancer as this drug combination may offer better tumor responses. However, the drugs may antagonize the cytotoxic capacity of each other due to cell cycle pertur
Publikováno v:
International journal of radiation oncology, biology, physics. 52(5)
Purpose: Pemetrexed disodium (Alimta, multitargeted antifolate, LY231514; Eli Lilly and Co., Indianapolis, Indiana) (“pemetrexed”) is a new folate antimetabolite with significant antitumor activity. Different from classic antifolates, pemetrexed
Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine
Autor:
Ralf Kinscherf, J. Doll, Annette Altmann, Johannes Blatter, Ulrike Traut, Matthias E. Bellemann, Huse Kamencic, Iris Morr, Gunnar Brix, Uwe Haberkorn
Publikováno v:
European journal of nuclear medicine. 28(4)
Apoptosis has been described as an energy-consuming process. This combined in vivo/in vitro study investigated the effects of the antineoplastic agent gemcitabine on tumour metabolism and on the induction of apoptosis. Dynamic positron emission tomog
Autor:
Michael Wannenmacher, D. Latz, Katharina Fleckenstein, Johannes Blatter, M.J. Eble, Klaus J. Weber
Publikováno v:
International journal of radiation oncology, biology, physics. 41(4)
Purpose: Gemcitabine (2′,2′-difluorodeoxycytidine; dFdCyd) is a new deoxycitidine analog which exhibits substantial activity against solid tumors and radiosensitizing properties in vitro. To examine cell cycle–specific effects of a combined tre
Autor:
Gerhard van Kaick, Jürgen Voges, Peter Dringst, Hans-Hermann Schrenk, E. A. Friedrich, J. H. Clorius, Christiane Werling, Malte L. Bahner, Volker Sturm, Hannsjörg Sinn, Hans-Georg Manke, Johannes Blatter
Publikováno v:
European journal of nuclear medicine. 22(9)
Systemic toxicity and inadequate tumour uptake of chemotherapeutic agents limit effective therapy of disseminated malignant disease. We seek to use macromolecules for improved delivery of therapeutic agents to tumours, and hope to use radiotracer pro